Patel and Saadabadi, 2025)
However, driven by shifts in dietary patterns and rising obesity rates, its incidence and prevalence are steadily increasing, with the disease increasingly manifesting in younger individuals ( Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a novel class of antidiabetic agents that activate the GLP-1 receptor to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner, delay gastric emptying, thereby controlling blood glucose and promoting weight loss ( Previous meta-analyses have primarily pooled the cardiovascular effects of GLP-1 RAs in patients with T2DM ( This study performed a systematic review and meta-analysis to evaluate the effects of subcutaneous vs
[10] Analyses of the SUSTAIN and PIONEER trial programs for semaglutide found no imbalance in cancer incidence across treatment groups
Ozempic and its GLP-1 peers have proven that substantial weight loss is possible with medication but theyre just the beginning
[ CrossRef ] [ Google scholar ] [ PubMed ] McMurry R, Perdomo C, Liu G, Zhang S, Stevenson C, Campbell J, et al
Jerusalem artichokes and chicory root contain high levels of inulin, a particularly effective prebiotic fiber